FNY Partners Fund’s BioCryst Pharmaceuticals BCRX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-4,000	Closed	-$20K	–	385
2017 Q3	$20K	Hold	4,000	–	–	﹤0.01%	351
2017 Q2	$22K	Buy	+4,000	New	+$22K	0.01%	313